QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)

ResMed (RMD) SEC Filings & 10K Form

$180.28
-0.38 (-0.21%)
(As of 02/21/2024 ET)

Recent ResMed SEC Filings

DateFilerForm TypeView
02/06/2024
10:21 AM
BLAISE LUCILE (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
6:50 PM
ResMed (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/03/2024
2:20 PM
Douglas Robert Andrew (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
6:45 PM
ResMed (Issuer)
Sandercock Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
4:26 PM
ResMed (Subject)
Sandercock Brett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
3:33 PM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:01 PM
BLAISE LUCILE (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2023
11:58 AM
BLAISE LUCILE (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
8:14 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4/A
11/20/2023
7:22 PM
Hernandez John (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
7:25 PM
De Witte Jan (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
7:28 PM
ResMed (Issuer)
SULPIZIO RICHARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
7:21 PM
Gill Harjit (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
5:53 PM
ResMed (Issuer)
Tan Desney (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
6:01 PM
Burt Carol (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
6:06 PM
Douglas Robert Andrew (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
5:45 PM
ResMed (Issuer)
TAYLOR RONALD R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
5:50 PM
FARRELL PETER C (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:21 PM
Ghoshal Kaushik (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:46 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:47 PM
Drexler Karen (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
8:20 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:47 PM
BLAISE LUCILE (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
7:28 PM
Ghoshal Kaushik (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
7:34 PM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
7:23 PM
Douglas Robert Andrew (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
7:07 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
6:33 PM
BLAISE LUCILE (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
6:00 PM
FARRELL PETER C (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
5:11 PM
Gill Harjit (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
9:09 AM
Farrell Michael J. (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
8:29 PM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
9:54 AM
ResMed (Subject)
Rider Michael J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/26/2023
6:38 PM
ResMed (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2023
5:50 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
9:15 AM
Farrell Michael J. (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/13/2023
4:00 PM
ResMed (Filer)
Form DEFR14A
10/05/2023
1:43 PM
ResMed (Filer)
Form DEF 14A
10/05/2023
1:45 PM
ResMed (Filer)
Form DEFA14A
10/05/2023
1:48 PM
ResMed (Filer)
Form ARS
10/04/2023
9:57 AM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
11:23 AM
ResMed (Subject)
Rider Michael J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2023
1:54 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
1:51 PM
Farrell Michael J. (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
2:44 PM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
9:50 AM
ResMed (Subject)
Rider Michael J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
4:56 PM
BLAISE LUCILE (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
12:02 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
12:03 PM
ResMed (Issuer)
Sandercock Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
12:06 PM
Ghoshal Kaushik (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
12:08 PM
BLAISE LUCILE (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
12:09 PM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
12:39 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
12:51 PM
Douglas Robert Andrew (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
9:58 AM
Douglas Robert Andrew (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
8:56 AM
Farrell Michael J. (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
7:15 PM
ResMed (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/02/2023
4:30 PM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
9:31 AM
ResMed (Subject)
Rider Michael J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
11:13 AM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
4:02 PM
Douglas Robert Andrew (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
2:23 PM
Douglas Robert Andrew (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2023
9:38 AM
Farrell Michael J. (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/14/2023
11:26 AM
Ghoshal Kaushik (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
10:41 AM
Ghoshal Kaushik (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/06/2023
1:30 PM
Nyxoah SA (Subject)
ResMed (Filed by)
Form SC 13G/A
07/05/2023
1:13 PM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
1:51 PM
ResMed (Subject)
Rider Michael J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2023
12:58 PM
ResMed (Issuer)
Rider Michael J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
10:23 AM
PENDARVIS DAVID (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
11:28 AM
PENDARVIS DAVID (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
11:02 AM
Douglas Robert Andrew (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:17 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
11:08 AM
Douglas Robert Andrew (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
8:55 AM
Farrell Michael J. (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
11:20 AM
PENDARVIS DAVID (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
12:18 PM
Ghoshal Kaushik (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
9:22 AM
PENDARVIS DAVID (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2023
1:44 PM
Ghoshal Kaushik (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/26/2023
12:16 PM
ResMed (Filer)
Form SD
Specialized Disclosure Report  
05/17/2023
1:10 PM
Farrell Michael J. (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
5:07 PM
Douglas Robert Andrew (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
10:35 AM
Farrell Michael J. (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2023
10:33 AM
Douglas Robert Andrew (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2023
6:30 PM
ResMed (Issuer)
Sandercock Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
4:12 PM
ResMed (Subject)
Sandercock Brett (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2023
4:16 PM
ResMed (Issuer)
Sandercock Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
6:49 PM
PENDARVIS DAVID (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
9:56 AM
PENDARVIS DAVID (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2023
7:04 AM
Ghoshal Kaushik (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2023
9:50 AM
Ghoshal Kaushik (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2023
6:34 PM
Ghoshal Kaushik (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2023
10:02 AM
Ghoshal Kaushik (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/18/2023
8:10 PM
Douglas Robert Andrew (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2023
2:24 PM
Douglas Robert Andrew (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2023
8:54 AM
Farrell Michael J. (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2023
3:42 PM
Nyxoah SA (Subject)
ResMed (Filed by)
Form SC 13G
04/05/2023
2:26 PM
Ghoshal Kaushik (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2023
2:28 PM
PENDARVIS DAVID (Reporting)
ResMed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2023
4:56 PM
Ghoshal Kaushik (Reporting)
ResMed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:RMD) was last updated on 2/21/2024 by MarketBeat.com Staff